Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

THYROCARE TECHNOLOGIES vs DR. LAL PATHLABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    THYROCARE TECHNOLOGIES DR. LAL PATHLABS THYROCARE TECHNOLOGIES/
DR. LAL PATHLABS
 
P/E (TTM) x 49.1 56.7 86.6% View Chart
P/BV x 5.9 11.7 50.4% View Chart
Dividend Yield % 3.0 0.5 573.1%  

Financials

 THYROCARE TECHNOLOGIES   DR. LAL PATHLABS
EQUITY SHARE DATA
    THYROCARE TECHNOLOGIES
Mar-23
DR. LAL PATHLABS
Mar-23
THYROCARE TECHNOLOGIES/
DR. LAL PATHLABS
5-Yr Chart
Click to enlarge
High Rs9172,870 31.9%   
Low Rs4161,763 23.6%   
Sales per share (Unadj.) Rs99.5241.9 41.1%  
Earnings per share (Unadj.) Rs12.228.9 42.1%  
Cash flow per share (Unadj.) Rs19.546.9 41.5%  
Dividends per share (Unadj.) Rs18.0012.00 150.0%  
Avg Dividend yield %2.70.5 521.3%  
Book value per share (Unadj.) Rs100.1192.9 51.9%  
Shares outstanding (eoy) m52.9383.37 63.5%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x6.79.6 70.0%   
Avg P/E ratio x54.880.1 68.4%  
P/CF ratio (eoy) x34.249.4 69.3%  
Price / Book Value ratio x6.712.0 55.4%  
Dividend payout %148.041.5 356.7%   
Avg Mkt Cap Rs m35,277193,109 18.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1,0623,765 28.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m5,26720,169 26.1%  
Other income Rs m84417 20.2%   
Total revenues Rs m5,35120,586 26.0%   
Gross profit Rs m1,2374,898 25.3%  
Depreciation Rs m3871,502 25.8%   
Interest Rs m48375 12.9%   
Profit before tax Rs m8863,438 25.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2421,028 23.6%   
Profit after tax Rs m6442,411 26.7%  
Gross profit margin %23.524.3 96.7%  
Effective tax rate %27.429.9 91.5%   
Net profit margin %12.212.0 102.2%  
BALANCE SHEET DATA
Current assets Rs m3,4689,731 35.6%   
Current liabilities Rs m1,5094,698 32.1%   
Net working cap to sales %37.225.0 149.0%  
Current ratio x2.32.1 110.9%  
Inventory Days Days21838 568.8%  
Debtors Days Days613 46.0%  
Net fixed assets Rs m4,88113,721 35.6%   
Share capital Rs m529834 63.5%   
"Free" reserves Rs m4,76815,247 31.3%   
Net worth Rs m5,29816,080 32.9%   
Long term debt Rs m0833 0.0%   
Total assets Rs m8,34823,451 35.6%  
Interest coverage x19.310.2 190.4%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.60.9 73.4%   
Return on assets %8.311.9 69.8%  
Return on equity %12.115.0 81.0%  
Return on capital %17.622.5 78.2%  
Exports to sales %00-   
Imports to sales %0.70.5 134.9%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m36101 35.2%   
Fx inflow Rs m38220 17.2%   
Fx outflow Rs m36101 35.2%   
Net fx Rs m2119 1.8%   
CASH FLOW
From Operations Rs m1,2934,560 28.4%  
From Investments Rs m-390-2,873 13.6%  
From Financial Activity Rs m-862-2,832 30.4%  
Net Cashflow Rs m41-1,145 -3.6%  

Share Holding

Indian Promoters % 71.1 52.6 135.3%  
Foreign collaborators % 0.0 2.0 -  
Indian inst/Mut Fund % 17.2 34.9 49.4%  
FIIs % 3.4 25.4 13.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 28.9 45.4 63.6%  
Shareholders   68,844 149,901 45.9%  
Pledged promoter(s) holding % 100.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare THYROCARE TECHNOLOGIES With:   APOLLO HOSPITALS    METROPOLIS HEALTHCARE    NARAYANA HRUDAYALAYA    KIMS    KOVAI MEDICAL    


More on THYROCARE TECHNOLOGIES vs DR. LAL PATHLABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

THYROCARE TECHNOLOGIES vs DR. LAL PATHLABS Share Price Performance

Period THYROCARE TECHNOLOGIES DR. LAL PATHLABS S&P BSE HEALTHCARE
1-Day 5.48% -0.28% 1.18%
1-Month -13.05% -2.16% -0.75%
1-Year 41.20% 24.99% 61.82%
3-Year CAGR -12.16% -4.74% 18.16%
5-Year CAGR 2.51% 16.06% 19.79%

* Compound Annual Growth Rate

Here are more details on the THYROCARE TECHNOLOGIES share price and the DR. LAL PATHLABS share price.

Moving on to shareholding structures...

The promoters of THYROCARE TECHNOLOGIES hold a 71.1% stake in the company. In case of DR. LAL PATHLABS the stake stands at 54.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of THYROCARE TECHNOLOGIES and the shareholding pattern of DR. LAL PATHLABS.

Finally, a word on dividends...

In the most recent financial year, THYROCARE TECHNOLOGIES paid a dividend of Rs 18.0 per share. This amounted to a Dividend Payout ratio of 148.0%.

DR. LAL PATHLABS paid Rs 12.0, and its dividend payout ratio stood at 41.5%.

You may visit here to review the dividend history of THYROCARE TECHNOLOGIES, and the dividend history of DR. LAL PATHLABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.